Significant Ownership of Schonfeld Strategic Advisors LLC

Signature - Title
/s/ Hung Luc - Hung Luc, Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Schonfeld Strategic Advisors LLC.

Notify me when Schonfeld Strategic Advisors LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Schonfeld Strategic Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MRSN Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.5% $2,122,973 -$41,906,118 273,579 -95% Schonfeld Strategic Advisors LLC 30 Sep 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% $9,901,969 -$2,137,399 4,305,204 -18% Schonfeld Strategic Advisors LLC 31 Mar 2025
SKYE Skye Bioscience, Inc. Common Stock, par value $0.001 per share 3.6% $3,861,149 -$1,736,083 1,115,939 -31% Schonfeld Strategic Advisors LLC 30 Jun 2025
APLT Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $1,496,351 -$1,309,934 4,676,097 -47% Schonfeld Strategic Advisors LLC 31 Mar 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 2.8% $762,651 1,314,915 Schonfeld Strategic Advisors LLC 31 Dec 2024
FATE Fate Therapeutics, Inc. Common Stock, par value $0.001 per share 0.82% $1,050,024 -$7,679,831 937,521 -88% Schonfeld Strategic Advisors LLC 30 Jun 2025

Schedules 13D/G Reported by Schonfeld Strategic Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.